Health Care Roundup: Market Talk

The latest Market Talks covering the Health Care sector. Published exclusively connected Dow Jones Newswires astatine 4:20 ET, 12:20 ET and 16:50 ET.

0854 GMT – Sandoz’s guidance for 2025 is weaker than expected and excludes the interaction of tariffs, which could measurement connected its outlook, Intron Health’s Naresh Chouhan and Dominic Rose accidental successful a probe note. The Swiss drugmaker expects mid-single digit income maturation astatine changeless currency and a halfway Ebitda borderline of 21%. This implies a 5% chopped to statement expectations for income and a 6% downgrade connected halfway Ebitda, Intron says. “We judge the top-line guidance is apt blimpish but we expect higher R&D walk going guardant to money the biosimilar pipeline,” the analysts say. Shares emergence 4.8%. ([email protected])

Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8